High-Risk Patients Awaiting Liver Transplant Benefit Most From Living Donors
WEDNESDAY, Oct. 11, 2023 -- High-risk cirrhosis patients awaiting liver transplant (LT) most benefit from potential living donors, according to a study published online Sept. 2 in Aging.
Fakhar Ali Qazi Arisar, M.B.B.S., from the University of...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Cirrhosis | Liver | Liver Transplant | Pharmaceuticals | Study | Transplant Surgery | Transplants | Urology & Nephrology